Загрузка...
Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy Related Toxicities
Chimeric antigen receptor T-cell (CAR-T) therapy has proven to be a very effective cancer immunotherapy. Axicabtagene ciloleucel and Tisagenlecleucel are the first in class anti-CD19 CAR-T-cells currently available for relapsed-refractory adult large B-cell lymphoma. Tisagenlecleucel is also availab...
Сохранить в:
| Опубликовано в: : | BioDrugs |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733400/ https://ncbi.nlm.nih.gov/pubmed/30560413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0324-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|